NCT01134341 2019-12-18Pralatrexate and Bexarotene in Patients With Relapsed or Refractory Cutaneous T-cell LymphomaAcrotech Biopharma Inc.Phase 1 Completed34 enrolled
NCT01007448 2019-11-12Study Evaluating Two Dose Levels of Targretin Capsules in Participants With Refractory Cutaneous T-Cell Lymphoma (CTCL)Bausch Health Americas, Inc.Phase 4 Completed59 enrolled 17 charts